Found 15 matching trials
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma PHASE2 Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
A Phase II, Multi-Center, Open-Label, Uncontrolled Study to Evaluate the Efficacy and Safety of Sorafenib Given Daily in Combination With Repeated 21-Day Cycles of Dacarbazine (DTIC) Chemotherapy in Subjects With Advanced Metastatic Melanoma PHASE2 The purpose of this study is to see whether a new type of anti-cancer drug,...
Show More Location
Multiple Locations
Learn More & Join Trial
Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable Melanoma PHASE2 RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in differ...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme PHASE2 The mechanism of action of sorafenib makes it an interesting drug to invest...
Show More Location
Florida Cancer Specialists
Learn More & Join Trial
Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma PHASE1 RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of...
Show More Location
Institut Gustave Roussy
Learn More & Join Trial
Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors PHASE2 This protocol will study treatment for Ewing sarcoma family of tumors (ESFT...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors PHASE1 This study will evaluate the safety and tolerability of R1507 in combinatio...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma PHASE2 The goal of this clinical research study is to find the highest tolerable d...
Show More Location
Multiple Locations
Learn More & Join Trial
ABT-888 and Temozolomide for Liver Cancer PHASE2 This study is for people with liver cancer (also called hepatocellular carc...
Show More Location
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Learn More & Join Trial
Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma PHASE1 The goal of this clinical research study is to find the highest tolerable d...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial